# QIT · Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/productcode/QIT

## Overview

- **Product Code:** QIT
- **Device Name:** Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)

## Identification

Intended to be worn on the surface of the eye in children who have myopia to:  •	Reduce the rate of progression of myopia, and  •	Optically correct myopic refractive error.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P180035](/device/P180035.md) | MiSight 1 Day (omafilcon A) Soft (Hydrophilic) Contact Lenses for Daily Wear | CooperVision, Inc. | Nov 15, 2019 | APPR |

## Top Applicants

- CooperVision, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/productcode/QIT](https://fda.innolitics.com/productcode/QIT)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com